top
Search terms
Results 1 - 10 of 15 - ordered by :
Pages: 1 2
Eurointervention

EuroIntervention Impact of proton-pump inhibitors on clinical outcomes in patients treated with a six-month or 24-month DAPT duration: insights from the PRODIGY trial METHODS AND RESULTS We assessed ...

Date : 06/05/2016 Item size : 31498 bytes
Eurointervention

EuroIntervention Impact of stent type and prolonged DAPT on long-term clinical outcomes in haemodialysis patients with coronary artery disease Asami M., Aoki J., Sato T., Tanimoto S., Watanabe M., ...

Date : 06/05/2016 Item size : 31385 bytes
Eurointervention

EuroIntervention Plasma miR-126 as a potential marker predicting major adverse cardiac events in dual antiplatelet-treated patients after percutaneous coronary intervention Department of Cardiology, ...

Date : 27/09/2013 Item size : 35795 bytes
Eurointervention

EuroIntervention Duration of dual antiplatelet therapy and clinical outcomes after drug-eluting stent implantation in patients presenting with acute coronary syndrome Coronary interventions Aims: ...

Date : 22/01/2015 Item size : 31663 bytes
Eurointervention

Coronary interventions Aims: Antiplatelet and anticoagulant adjunctive therapies are associated with an increased risk of major bleeding that adversely impacts on clinical outcomes. All patients ...

Date : 22/01/2015 Item size : 31346 bytes
Date : 05/08/2016 Item size : 103539 bytes
Ehjqcco

Abstract Aims There is a paucity of real-world, contemporary data of practice patterns and clinical outcomes following dual-antiplatelet therapy (DAPT) in acute myocardial infarction (AMI) patients ...

European Heart Journal - Quality of Care and Clinical Outcomes, Original Article, Juan J. Russo, Shaun G. Goodman, Akshay Bagai, Jean-Pierre Déry, Mary K. Tan, Harold N. Fisher, Xiang Zhang, Yajun ...

Date : 15/10/2016 Item size : 316571 bytes
Ehjournal

[...]post-CHARISMA, we agree that there is no established role for dual antiplatelet therapy in primary prevention.2 Aspirin appears to have a role in primary prevention, but even then, only after ...

European Heart Journal, Wang, Thomas, Bhatt, Deepak L.

Date : 02/07/2006 Item size : 94343 bytes
Escardio

A five years post-hoc sub-analysis of ORAR 3 trial Alfredo Matias RODRIGUEZ-GRANILLO (Buenos Aires, AR) 08:30 P5471 Factors influencing clinical decision making for cessation of dual antiplatelet ...

Poster session 6: PCI long-term outcome

Date : 02/09/2014 Item size : 105500 bytes
Escardio

11:00 P817 SCAD management, controversies; in the stent era Abtehale AL-HUSSAINI (Leicester, United Kingdom) 11:00 P818 Outcome of patients with atrial fibrillation submitted to percutaneous coronary ...

Poster session 1: Early and late outcomes after PCI II

Date : 29/08/2015 Item size : 98827 bytes